Market Research Report
ASIA PACIFIC BETA GLUCAN MARKET FORECAST 2018-2026
|Published by||Inkwood Research||Product code||636634|
|Published||Content info||92 Pages
Delivery time: 1-2 business days
|ASIA PACIFIC BETA GLUCAN MARKET FORECAST 2018-2026|
|Published: May 14, 2018||Content info: 92 Pages||
The Asia-Pacific beta glucan market is expected to showcase a CAGR of 7.61% during the forecast period of 2018-2026. China dominated the beta glucan market in this region with a revenue of $xx million in 2017. The country is also expected to register the highest CAGR in the Asia-Pacific market over the forecast period.
The beta glucan market is segmented on the basis of end-users, category and sources. Apart from China, the other key markets in this region include India, Japan, Australia and South Korea. High disposable income, growing prevalence of cancer and increasing demand from the bakery industry are expected to drive the need for the Asia-Pacific beta-glucan market.
Some of the noted market players in this market are Chr. Hansen A/S, Koninklijke Dsm N.V, Kemin Industries, Alltech Biotechnology, Super Beta Glucan, Pharmacon Asa, Kerry Group Plc, Specialty Biotech Ltd, Milliporesigma (Merck), Cargill Inc, Tate & Lyle Plc, Garuda International Inc and Frutarom.